|
|
|
|
LEADER |
02452 am a22003853u 4500 |
001 |
85068 |
042 |
|
|
|a dc
|
100 |
1 |
0 |
|a Narayan, Kavitha
|e author
|
100 |
1 |
0 |
|a Massachusetts Institute of Technology. Department of Biology
|e contributor
|
100 |
1 |
0 |
|a Regev, Aviv
|e contributor
|
700 |
1 |
0 |
|a Sylvia, Katelyn E.
|e author
|
700 |
1 |
0 |
|a Malhotra, Nidhi
|e author
|
700 |
1 |
0 |
|a Yin, Catherine C.
|e author
|
700 |
1 |
0 |
|a Martens, Gregory
|e author
|
700 |
1 |
0 |
|a Vallerskog, Therese
|e author
|
700 |
1 |
0 |
|a Kornfeld, Hardy
|e author
|
700 |
1 |
0 |
|a Xiong, Na
|e author
|
700 |
1 |
0 |
|a Cohen, Nadia R.
|e author
|
700 |
1 |
0 |
|a Brenner, Michael B.
|e author
|
700 |
1 |
0 |
|a Berg, Leslie J.
|e author
|
700 |
1 |
0 |
|a Kang, Joonsoo
|e author
|
700 |
1 |
0 |
|a Immunological Genome Project Consortium
|e author
|
700 |
1 |
0 |
|a Regev, Aviv
|e author
|
245 |
0 |
0 |
|a Intrathymic programming of effector fates in three molecularly distinct γδ T cell subtypes
|
260 |
|
|
|b Nature Publishing Group,
|c 2014-02-21T18:20:11Z.
|
856 |
|
|
|z Get fulltext
|u http://hdl.handle.net/1721.1/85068
|
520 |
|
|
|a PMC 2012 November 01
|
520 |
|
|
|a Innate γδ T cells function in the early phase of immune responses. Although innate γδ T cells have often been studied as one homogenous population, they can be functionally classified into effector subsets on the basis of the production of signature cytokines, analogous to adaptive helper T cell subsets. However, unlike the function of adaptive T cells, γδ effector T cell function correlates with genomically encoded T cell antigen receptor (TCR) chains, which suggests that clonal TCR selection is not the main determinant of the differentiation of γδ effector cells. A high-resolution transcriptome analysis of all emergent γδ thymocyte subsets segregated on the basis of use of the TCR γ-chain or δ-chain indicated the existence of three separate subtypes of γδ effector cells in the thymus. The immature γδ subsets were distinguished by unique transcription-factor modules that program effector function.
|
520 |
|
|
|a National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) (Diabetes and Endocrinology Research Center, DK32520)
|
520 |
|
|
|a National Institutes of Health (U.S.) (R24 AI072073 to the ImmGen group)
|
520 |
|
|
|a National Institutes of Health (U.S.) (CA100382)
|
520 |
|
|
|a National Institute of Allergy and Infectious Diseases (U.S.)
|
546 |
|
|
|a en_US
|
655 |
7 |
|
|a Article
|
773 |
|
|
|t Nature Immunology
|